Department of Internal Medicine, Dell Medical School at the University of Texas, Austin, Texas.
Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, San Diego, California, USA.
Curr Opin Cardiol. 2022 Jul 1;37(4):335-342. doi: 10.1097/HCO.0000000000000958.
There continues to be extensive clinical and epidemiological data to suggest that coronavirus disease 2019 (COVID-19) infection is associated with numerous different types of cardiac involvement.
Myocardial injury has been reported in over 25% of patients hospitalized due to COVID-19 infection and is not only associated with a worse prognosis but with higher mortality, approaching 40%. Currently proposed mechanisms of myocardial injury include direct viral infection, cytokine storm, endothelial inflammation, demand ischemia, interferon-mediated response and stress cardiomyopathy. COVID-19 infection is associated with new-onset arrhythmias and heart failure regardless of history of previous cardiovascular disease. Echocardiographic findings can be useful to predict mortality in COVID-19 patients and cardiac MRI is an effective tool to both assess COVID-19 induced myocarditis and to follow-up on cardiac complications of COVID-19 long-term. Although there is an association between COVID-19 vaccination and myocarditis, pericarditis or arrhythmias, the risk appears lower when compared to risk attributable to the natural infection.
Patients with cardiovascular disease are not only more likely to suffer from severe COVID-19 infection but are at increased risk for further complications and higher mortality. Further data compilation on current and emerging treatments of COVID-19 will have additional impact on cardiovascular morbidity and mortality of COVID-19 infection.
有大量的临床和流行病学数据表明,2019 年冠状病毒病(COVID-19)感染与多种不同类型的心脏受累有关。
因 COVID-19 感染住院的患者中,超过 25%的患者报告有心肌损伤,且心肌损伤不仅与预后更差有关,而且与更高的死亡率(接近 40%)有关。目前提出的心肌损伤机制包括病毒直接感染、细胞因子风暴、内皮炎症、需求性缺血、干扰素介导的反应和应激性心肌病。COVID-19 感染与新发心律失常和心力衰竭有关,无论患者之前是否有心血管疾病史。超声心动图检查结果有助于预测 COVID-19 患者的死亡率,心脏 MRI 是一种有效的工具,既能评估 COVID-19 引起的心肌炎,也能对 COVID-19 长期的心脏并发症进行随访。尽管 COVID-19 疫苗接种与心肌炎、心包炎或心律失常之间存在关联,但与自然感染相比,这种风险似乎较低。
心血管疾病患者不仅更容易患严重的 COVID-19 感染,而且发生进一步并发症和更高死亡率的风险也更高。关于 COVID-19 目前和新兴治疗方法的进一步数据汇总将对 COVID-19 感染的心血管发病率和死亡率产生额外影响。